Here, we addressed these questions and demonstrated that ginsenoside Rb2 regulates epidermal growth factor receptor (EGFR), as well as its downstream targets, leading to inhibition of CRC metastasis. The gene discussed is EGFR; the disease is colorectal carcinoma.